Patents by Inventor Martin Harmsen

Martin Harmsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ENDOTHELIAL PROGENITOR CELL COMPOSITIONS AND NEOVASCULARIZATION
    Publication number: 20100034794
    Abstract: Methods and compositions are provided for inducing neovascularization in injured tissues with endothelial progenitor cells (EPCs). Mixtures of purified CD34+ endothelial progenitors and purified CD14+ monocytes, or products of an in vitro co-culture of purified CD34+ endothelial progenitor cells and purified CD14+ monocytes provide neovascularization after administration to a subject having a tissue injury, such as an ischemic injury.
    Type: Application
    Filed: October 2, 2007
    Publication date: February 11, 2010
    Inventors: Barry W.A. van der Strate, Guido Krenning, Brian C.A. Fernandes, Martin Harmsen, Marja J.A. van Luyn, Didier Billy, Marc Hendriks
  • Isolation of endothelial progenitor cell subsets and methods for their use
    Publication number: 20060035290
    Abstract: A method is provided for the isolation of endothelial progenitor cells from a source of progenitor cells by isolating a population of lineage-negative cells and further isolating CD34+ cells from the lineage-negative population by fluorescence-activated cell sorting. Isolated populations of endothelial progenitor cells and therapeutic compositions containing CD34+ cells for the induction of blood vessels, induction of angiogenic responses in surrounding blood vessels and the chemotaxis of inflammatory cells are also provided.
    Type: Application
    Filed: August 11, 2005
    Publication date: February 16, 2006
    Applicant: Medtronic, Inc.
    Inventors: Eliane Popa, Martin Harmsen, Barry van der Strate, Marja van Luyn, Marc Hendriks